🇺🇸 FDA
Pipeline program

BNT116, LIBTAYO 350 mg concentrate for solution for infusion.

R2810-ONC-2045

Phase 2 small_molecule active

Quick answer

BNT116, LIBTAYO 350 mg concentrate for solution for infusion. for Advanced Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Advanced Non-Small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials